Knowledge, attitude, and practices of Nigerians relating to the use of triple action creams: Results of a study among patrons of Community Pharmacies in Oshodi/Isolo Local Government, Lagos State, Nigeria
Keywords:
Topical Corticosteroids, Triple action creams, Skin disease, Community PharmaciesAbstract
Background: Triple action creams are employed for the treatment of a variety of skin or topical conditions. Over-the-counter availability of all strengths in Nigeria has raised concerns regarding its use for non-labelled indications. This study aims to assess the Knowledge, Attitude and Practices of Nigerians relating to the use of triple action creams.
Methods: The study was a cross sectional descriptive survey carried out among Nigerian patrons of Community Pharmacies located in three wards of Oshodi/Isolo Local Government, Lagos State, Nigeria. A multistage sampling was done to recruit participants used for the study. A 12-item self administered questionnaire was used to elicit information from the respondents who consented to participate in the study.
Results: Atotal of 384 respondents recruited completed the survey of which more than half (70.1%) of the study respondents are not aware of the long-term complications associated with misuse and abuse of triple action creams. Faster result (60.9%), brighter fair skin (58.6%) and lack of knowledge about the complications (64.3%) are the major reasons behind the misuse.
Conclusion: There is a low level of awareness of the Nigerian populace relating to the long-term complications of use triple action creams. There is therefore a dire need to adequately equip the populace with drug information as well as educate the public on the limits and acceptable attitudes and practices relating to the use of Topical Corticosteroids.
References
Paek SY, Koriakos A, Saxton-Daniels S, Pandya AG (2012) Skin diseases in rural Yucatan, Mexico. International Journal of Dermatology 51(7):823-8. https://doi.org/10.1111/j.1365-4632.2011.05190.x.
World Health Organization, (2005)Epidemiology and management of common skin diseases in children in developing countries. Department of Child and Adolescent Health and Development, Geneva, Switzerland. [Cited 27 Nov 2019] Available from: https://apps.who.int/iris/handle/10665/69229
Svensson A, Ofenloch RF, Bruze M, Naldi L, Cazzaniga S, Elsner P, Goncalo M, Schuttelaar MA, Diepgen TL (2018) Prevalence of skin disease in a population-based sample of adults from five European countries. British Journal of Dermatology 178(5): 1111 - 1118. https://doi.org/10.1111/bjd.16248
Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, Nsoesie EO, Ferrari AJ, Erskine HE, Silverberg JI, Vos T, Naghavi M (2017) Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013. JAMA Dermatol 153 (5): 406 - 412.https://doi.org/10.1001/jamadermatol.2016.5538
Coondoo A (2014) Topical corticosteroid misuse: The Indian Scenario. Indian Journal of Dermatology [Online]; 59:451-5 Available at: http://www.e-ijd.org/t ext.asp?2014/59/5/451/139870 [Accessed 27 Nov 2019]
Rathi S (2006) Abuse of topical steroid as cosmetic cream: A social background of steroid dermatitis. Indian Journal of Dermatology [Online] 51:154-5 Available from: http://www.eijd.org/text.asp?2006/51/2/154/26949 [Accessed 27 Nov 2019]
Manzoor S, Shahab ud din Bukhari S, Rather S (2017) Topical steroid abuse: clinicoepidemiological profile. International
Journal of Contemporary Medical Research 4(7):1454–6.
Hengge UR, Ruzicka T, Schwartz RA, Cork MJ (2006) Adverse effects of topical glucocorticosteroids. Journal of American
Academy of Dermatology 54(1):1–8.https://doi.org/10.1016/j.jaad.2005.01.010
Nnoruka E and Okoye O (2006) Topical Steroid Abuse: It's Use as a Depigmenting Agent. Journal of the National Medical Association 98(6): 934-938.
Estrada-Chávez G, Estrada R, Engelman D, Molina J, Chávez-López G (2018) Cushing Syndrome due to Inappropriate Corticosteroid Topical Treatment of Undiagnosed Scabies. Trop Med Infect Dis. 3(3): 82. https://doi.org/10.3390/tropicalmed3030082
Fat, C. L. and Leslie, T. (2011) Irreversible visual loss secondary to excessive topical steroid use in eczema. The British journal of general practice: the journal of the Royal College of General Practitioners 61(590): 583 – 584.
https://doi.org/10.3399/bjgp11X594054
Malangu N and Ogunbanjo GA (2006) Predictors of topical steroid misuse among patrons of pharmacies in Pretoria. South African Family Practice, 48:1, 14 - 14e. https://doi.org/10.1080/20786204.2006.10873312
Sagoe D, Pallesen S, Dlova NC, Lartey M, Ezzedine K, Dadzie O (2019) The global prevalence and correlates of skin bleaching: a meta-analysis and meta-regression analysis. Int J Dermatol. 58 (1): 24 - 44 . https://doi.org/10.1111/ijd.14052
Arinola E.J, Oluwatosin A. O and Olusola O.A (2017) Management of skin diseases among community pharmacists in Lagos, Nigeria. West African Journal of Pharmacy 28(1):23-34.
Chu AC (2008). Antibacterial/steroid combination therapy in infected eczema. Acta Dermato-Venereol.;Suppl. 216:28–34.
Wheat CM, Bickley RJ, Hsueh YH (2017) Current trends in the use of two combination antifungal/corticosteroid creams. Journal of Pediatrics 186:192–5.
Ibekwe, P.U., Henshaw, E.B. & Okudo, G.C. (2018) Knowledge of potency and formulations of topical corticosteroids among drug vendors in the Federal Capital Territory of Nigeria. Drugs Therapy Perspectives 34: 522 – 527. https://doi.org/10.1007/s40267-018-0544-9
Lau WM, Donyai P (2017) Knowledge, attitude and advice-giving behavior of community pharmacists regarding topical corticosteroids. Pharmacy (Basel) 5(3): 41. https://doi.org/10.3390/pharm acy503
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
